Literature DB >> 26454434

Current status of rotavirus vaccines.

Ching-Min Wang1,2, Shou-Chien Chen1,3,4, Kow-Tong Chen5,6,7.   

Abstract

BACKGROUND: Rotaviruses remain the major cause of childhood diarrheal disease worldwide and of diarrheal deaths of infants and children in developing countries. The huge burden of childhood rotavirus-related diarrhea in the world continues to drive the remarkable pace of vaccine development. DATA SOURCES: Research articles were searched using terms "rotavirus" and "rotavirus vaccine" in MEDLINE and PubMed. Articles not published in the English language, articles without abstracts, and opinion articles were excluded from the review. After preliminary screening, all articles were reviewed and synthesized to provide an overview of current vaccines and vaccination programs.
RESULTS: In this review of the global rotavirus vaccines and vaccination programs, the principles of rotavirus vaccine development and the efficacy of the currently licensed vaccines from both developed and developing countries were summarized.
CONCLUSIONS: Rotavirus is a common cause of diarrhea in children in both developed and developing countries. Rotavirus vaccination is a cost-effective measure to prevent rotavirus diarrhea.

Entities:  

Keywords:  cost-effectiveness; efficacy; rotavirus; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26454434     DOI: 10.1007/s12519-015-0038-y

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  86 in total

1.  Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate.

Authors:  G L Barnes; J S Lund; L Adams; A Mora; S V Mitchell; A Caples; R F Bishop
Journal:  J Paediatr Child Health       Date:  1997-08       Impact factor: 1.954

2.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

Review 3.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

Review 4.  Rotavirus vaccines in routine use.

Authors:  Jacqueline E Tate; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2014-07-21       Impact factor: 9.079

5.  Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.

Authors:  C F Lanata; R E Black; R del Aguila; A Gil; H Verastegui; G Gerna; J Flores; A Z Kapikian; F E Andre
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

6.  Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.

Authors:  I Perez-Schael; D Garcia; M Gonzalez; R Gonzalez; N Daoud; M Perez; W Cunto; A Z Kapikian; J Flores
Journal:  J Med Virol       Date:  1990-03       Impact factor: 2.327

7.  Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants.

Authors:  M L Clements-Mann; M K Makhene; J Mrukowicz; P F Wright; Y Hoshino; K Midthun; E Sperber; R Karron; A Z Kapikian
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

8.  Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial.

Authors:  Yu-Lung Lau; E Anthony S Nelson; Kin-Hung Poon; Paul K S Chan; Susan Chiu; Rita Sung; Chi Wai Leung; Daniel Ng; Yee Man Ma; Desmond Chan; Tsz Leung Lee; Joyce Tang; Yat Wah Kwan; Patricia Ip; Marco Ho; Lai-Wah Eva Fung; Haiwen Tang; P V Suryakiran; Htay Htay Han; Hans Bock
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

9.  Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.

Authors:  Brynley P Hull; Robert Menzies; Kristine Macartney; Peter B McIntyre
Journal:  Vaccine       Date:  2013-02-17       Impact factor: 3.641

10.  Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.

Authors:  Vesta Richardson; Joselito Hernandez-Pichardo; Manjari Quintanar-Solares; Marcelino Esparza-Aguilar; Brian Johnson; Cesar Misael Gomez-Altamirano; Umesh Parashar; Manish Patel
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

View more
  7 in total

Review 1.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

2.  Molecular Analysis of VP7 Gene of Rotavirus G1 Strains Isolated from North India.

Authors:  Swapnil Jain; Jitendraa Vashistt; Kanika Gupta; Ashok Kumar; Harish Changotra
Journal:  Curr Microbiol       Date:  2016-08-26       Impact factor: 2.188

Review 3.  Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection.

Authors:  Julio Villena; Maria Guadalupe Vizoso-Pinto; Haruki Kitazawa
Journal:  Front Immunol       Date:  2016-12-05       Impact factor: 7.561

4.  Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.

Authors:  Sanjeev Agarwal; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534

5.  The prevalence and genotype distribution of rotavirus A infection among children with acute gastroenteritis in Kunming, China.

Authors:  Ziqin Dian; Mao Fan; Binghui Wang; Yue Feng; Hao Ji; Shuwei Dong; A-Mei Zhang; Li Liu; Hua Niu; Xueshan Xia
Journal:  Arch Virol       Date:  2016-10-07       Impact factor: 2.574

Review 6.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

7.  Human intestinal models to study interactions between intestine and microbes.

Authors:  Arturo Aguilar-Rojas; Jean-Christophe Olivo-Marin; Nancy Guillen
Journal:  Open Biol       Date:  2020-10-21       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.